article thumbnail

Magazine: CRISPR gene therapies cut through in 2023

Pharmaceutical Technology

The post Magazine: CRISPR gene therapies cut through in 2023 appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.

FDA 98
article thumbnail

Magazine: Enhancing therapy adherence with prodrugs

Pharmaceutical Technology

In this issue: Solving adherence issues with prodrugs, examining whether PBMs are to blame for high drugs prices in the US, developing vaccines for Disease X, and more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Magazine-How delays derailed Covid-19 vaccination in Africa

Pharmaceutical Technology

The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.

Vaccines 110
article thumbnail

Magazine: Left in limbo: when pharma halts rare disease research

Pharmaceutical Technology

Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might be rare. But when funds are limited and the market potential is dim, such programs are often abandoned by companies, leaving patients and investigators in a bind.

98
article thumbnail

Magazine: What Rishi Sunak can do for the UK pharma industry

Pharmaceutical Technology

The post Magazine: What Rishi Sunak can do for the UK pharma industry appeared first on Pharmaceutical Technology. All this, and the latest pharma industry news , comment, data, and analysis from GlobalData. Click here to view the latest issue of Pharmaceutical Technology Focus.

93
article thumbnail

Magazine: Cell and gene therapy approvals drive paradigm change in manufacturing

Pharmaceutical Technology

In this issue: The manufacturing shift to meet growing cell and gene therapy demand, applying lessons from the Covid-19 pandemic to address mpox, a ten-year review of Opdivo and Keytruda, and more.

52
article thumbnail

Magazine: UK’s new Netflix-style funding model for antibiotics goes live

Pharmaceutical Technology

In this issue: UK’s new Netflix-style funding model for antibiotics, the Swiss biotech ecosystem recuperates from financial instability of 2023, how patient advocacy can lead to more successful clinical trials, and more.

96